U.S. completes withdrawal from WHO, reshaping global-health cooperation and funding

What the U.S. announced

The U.S. Department of Health and Human Services and the U.S. Department of State announced on January 22, 2026, that the United States completed its withdrawal from the World Health Organization. The statement cited dissatisfaction with the WHO’s handling of the COVID-19 pandemic, its governance and reform track record, and concerns about political influence.

The announcement described a yearlong withdrawal process that included stopping funding, withdrawing U.S. personnel, and shifting activities previously conducted with the WHO toward bilateral engagements and other partnerships. The U.S. said future coordination with the WHO would be limited and focused on effectuating the withdrawal.

Why markets and businesses care

For businesses, the decision can alter how disease surveillance data and technical guidance flow into U.S. public health planning, which in turn affects everything from workforce continuity and travel risk management to supply chains for medical products. Pharma and vaccine manufacturers also rely on predictable global coordination and information-sharing, particularly around emerging variants and seasonal strains.

Internationally, the U.S. exit also changes funding dynamics for programs that help stabilize health systems in lower-income countries—an indirect but meaningful factor for global economic stability, humanitarian logistics, and the risk profile of multinational operations in regions where outbreaks can disrupt trade.

How the U.S. says it will operate going forward

U.S. officials said the country would continue global health leadership through existing and new direct engagements with other countries, NGOs, private-sector partners, and faith-based entities, with priorities including emergency response, biosecurity coordination, and health innovation.

In practical terms, companies and institutions should expect adjustments in how technical cooperation is structured—potentially more bilateral agreements and project-by-project collaboration rather than work routed through WHO mechanisms. The scale, speed, and consistency of those replacements will shape whether the transition increases uncertainty or produces a stable alternative framework.